Have you ever considered submitting a JAMA Clinical Challenge? JAMA is accepting submissions for gastrointestinal disease patient scenarios. #DDW2024 For criteria and information on Clinical Challenge submissions, visit: https://ja.ma/44IEkhJ
JAMA
Book and Periodical Publishing
Chicago, Illinois 147,155 followers
JAMA is an international peer-reviewed general medical journal published online daily and in print weekly.
About us
JAMA, published continuously since 1883, is an international peer-reviewed general medical journal. JAMA is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. JAMA is the most widely circulated general medical journal in the world, with more than 289,000 recipients of the print journal, more than 1.5 million recipients of electronic tables of contents and alerts, and over 30 million annual visits to the journal's website. JAMA is published 48 times per year in print/online issues, and new articles are published several times a week online. Without any author fees, all research articles are made free access online 6 months after publication on the JAMA website. In addition, the online version is freely available or nearly so to institutions in developing countries through the World Health Organization's HINARI program. Kirsten Bibbins-Domingo, PhD, MD, MAS, is the Editor in Chief of JAMA,. JAMA is a member of the International Committee of Medical Journal Editors, cosponsors the International Congress on Peer Review and Biomedical Publication, and is a member of the African Journal Partnership Project and is partnered with the Malawi Medical Journal. JAMA's key objective is to promote the science and art of medicine and the betterment of the public health. JAMA ISSN 0098-7484 (Print) ISSN 1538-3598 (Online)
- Website
-
http://ja.ma/JAMA
External link for JAMA
- Industry
- Book and Periodical Publishing
- Company size
- 1,001-5,000 employees
- Headquarters
- Chicago, Illinois
- Type
- Nonprofit
- Founded
- 1883
- Specialties
- Internal Medicine, Dermatology, Neurology, Surgery, Pediatrics, Ophthalmology, Otolaryngology, General Psychiatry, Cardiology, Oncology, Health Policy, Psychiatry, Surgery, Cardiology, Hypertension, Cholesterol, Diabetes, and Cancer
Locations
-
Primary
330 N Wabash Ave
Chicago, Illinois 60611, US
Employees at JAMA
-
Jennifer Abbasi
-
Nicholas Reback
MA, CMI | Medical Illustrator & Designer at the JAMA Network | Owner/Principal at Reback Biomedical Media
-
Paul G.
Vice President, Product Management and Development
-
Roy Perlis
Associate Chief (Research), Department of Psychiatry at Massachusetts General Hospital
Updates
-
Cohort study assesses match rates of US applicants with and without disability into specialty residence programs. https://ja.ma/3UAYfuu
-
Provision of medications for self-managed abortions increased in the 6 months following the Dobbs decision. Results suggest that a substantial number of individuals accessed abortion services despite the implementation of state-level bans and restrictions. https://ja.ma/3wDAH07
-
In critically ill patients with sepsis, IV acetaminophen was safe but did not significantly improve days alive and free of organ support. #ATS2024 https://ja.ma/44QtZ3p
-
Editorial on BISC trial: "Ultimately, the decision to use β-blockers for any given patient with COPD without coexisting CV disease still requires careful consideration based on the data to date." #ATS2024 https://ja.ma/3UOE2Bk
-
Treatment with bisoprolol did not reduce the number of self-reported COPD exacerbations requiring treatment with oral corticosteroids, antibiotics, or both. #ATS2024 https://ja.ma/4dDNj8d
-
Editorial on ZEPHYRUS-1: When the Third Time Is Not the Charm The failure of different investigational drugs to progress from phase 2 to phase 3 is "a fundamental problem limiting the development of much-needed effective treatments for IPF." #ATS2024 https://ja.ma/3X468vx
-
Among patients with IPF treated with pamrevlumab or placebo, there was no statistically significant between-group difference for the primary outcome of absolute change in FVC from baseline to week 48. #ATS2024 https://ja.ma/3WPddQf
-
We are seeking images for JAMA Clinical Challenges. #DDW2024 If you have an #digestivedisease case that fits the criteria of a JAMA Clinical Challenge, learn how to submit yours: https://ja.ma/4ama11N
-
Read this Review article to learn more about hepatitis D infection. https://ja.ma/3V11Of4